Pharmaloz Manufacturing signs deals with two lozenge brands

Pharmaloz Manufacturing signed contracts with two top-tier lozenge brands, projected to add $5 million in annual revenue and over $1.25 million in yearly pre-tax net profits.

“PMI has signed deals with two top-tier lozenge brands.”biospace.com

• 1 source
• biospace.comPharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsGabrielle MassonJan 23, 2024

Summarized from public sources; check the original articles before acting on it.